Respa C&C IR Drug Interactions
Currently displaying 101 drugs known to have a major interaction with Respa C&C IR (acetaminophen / dextromethorphan / diphenhydramine / phenylephrine).
- 101 major drug interactions
- 577 moderate drug interactions
- 15 minor drug interactions
Major interactions with Respa C&C IR (acetaminophen / dextromethorphan / diphenhydramine / phenylephrine)
Note: Showing generic names only.
- desipramine
- desvenlafaxine
- dexfenfluramine
- dihydroergotamine
- dolasetron
- doxepin
- doxepin topical
- duloxetine
- lasmiditan
- leflunomide
- levoketoconazole
- levomethadyl acetate
- levomilnacipran
- linezolid
- lomitapide
- lorcaserin
- maprotiline
- meperidine
- methotrimeprazine
- methylene blue
- methylergonovine
- methysergide maleate
- milnacipran
- mipomersen
- mirtazapine
- palonosetron
- paroxetine
- pentazocine
- pexidartinib
- phenelzine
- potassium chloride
- potassium citrate
- procarbazine
- propoxyphene
- protriptyline
- tamoxifen
- tapentadol
- terbinafine
- teriflunomide
- thioridazine
- topiramate
- tramadol
- tranylcypromine
- trazodone
- trimipramine
- tryptophan
Respa C&C IR alcohol/food interactions
There is 1 alcohol/food interaction with Respa C&C IR (acetaminophen / dextromethorphan / diphenhydramine / phenylephrine).
Respa C&C IR disease interactions
There are 15 disease interactions with Respa C&C IR (acetaminophen / dextromethorphan / diphenhydramine / phenylephrine) which include:
- alcoholism
- liver disease
- depression
- cardiovascular disease
- PKU
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- glaucoma
- liver disease
- resp depression
- BPH
- diabetes
- glaucoma
More about Respa C&C IR (acetaminophen / dextromethorphan / diphenhydramine / phenylephrine)
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.